These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11507877)

  • 1. [Spontaneous migration of blood neutrophils in mixed leukocyte population and its changes under the effect of auto-plasma substances in various functional states].
    Fedorova MZ; Levin VN
    Klin Lab Diagn; 2001; (5):16-9. PubMed ID: 11507877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiology of granulocyte locomotion and its relation to defects of chemotaxis: a review.
    Wilkinson PC
    J R Soc Med; 1979 Aug; 72(8):606-11. PubMed ID: 399647
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis.
    Schmekel B; Håkansson L; Hällgren R; Stålenheim G; Venge P
    Eur J Respir Dis; 1984 Nov; 65(8):592-9. PubMed ID: 6519214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.
    Nelson RD; Quie PG; Simmons RL
    J Immunol; 1975 Dec; 115(6):1650-6. PubMed ID: 1102606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic factors: an overview.
    Wilkinson PC
    Methods Enzymol; 1988; 162():127-32. PubMed ID: 3067049
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of culture filtrates of Blastomyces dermatitidis on neutrophil locomotion.
    Mitchell TG; Turner SR
    Sabouraudia; 1984; 22(2):145-53. PubMed ID: 6374935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic activity of C5ades Arg: evidence of a requirement for an anionic peptide 'helper factor' and inhibition by a cationic protein in serum from patients with systemic lupus erythematosus.
    Perez HD; Goldstein IM; Chernoff D; Webster RO; Henson PM
    Mol Immunol; 1980 Feb; 17(2):163-9. PubMed ID: 7393228
    [No Abstract]   [Full Text] [Related]  

  • 9. A modified leukocyte migration under agarose technique (LMAT). Technical aspects.
    Belsheim J
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):167-74. PubMed ID: 7032206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD; Hooper C; Volanakis J; Ueda A
    J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neutrophil chemotaxis and chemokinesis associated with a plasma protein in aging rats: selective depression of cell responses mediated by complement-derived chemoattractants.
    Mello SB; Farsky SH; Sannomiya P; Garcia-Leme J
    J Leukoc Biol; 1992 Jan; 51(1):46-52. PubMed ID: 1311013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocytes and neutrophil granulocytes differ in regulatory signaling and migratory dynamics with regard to spontaneous locomotion and chemotaxis.
    Entschladen F; Gunzer M; Scheuffele CM; Niggemann B; Zänker KS
    Cell Immunol; 2000 Feb; 199(2):104-14. PubMed ID: 10698620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of chemotaxis inhibitory activity in sera of patients with systemic lupus erythematosus.
    Hasegawa S; Baba T; Koitabashi Y; Shimizu Y; Sonozaki H; Hori Y; Nishiyama S
    J Dermatol; 1980 Oct; 7(5):309-15. PubMed ID: 7009680
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural inhibitors of leukotaxis.
    Ward PA
    Prog Clin Biol Res; 1977; 13():77-81. PubMed ID: 400762
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes.
    Repo H; Kostiala AA; Kosunen TU
    Immunology; 1978 Sep; 35(3):539-48. PubMed ID: 359465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium modulation and chemotactic response: divergent stimulation of neutrophil chemotaxis and cytosolic calcium response by the chemotactic peptide receptor.
    Meshulam T; Proto P; Diamond RD; Melnick DA
    J Immunol; 1986 Sep; 137(6):1954-60. PubMed ID: 3745918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils.
    Klyubin IV; Kirpichnikova KM; Gamaley IA
    Eur J Cell Biol; 1996 Aug; 70(4):347-51. PubMed ID: 8864663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polymorphonuclear leukocyte (PMNL) locomotor defect in juvenile periodontitis. Study of random migration, chemokinesis and chemotaxis.
    Van Dyke TE; Horoszewicz HU; Genco RJ
    J Periodontol; 1982 Nov; 53(11):682-7. PubMed ID: 6960166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.